Evidence map›Paper›PMID 33998849›Full record

ArticleCannabis and cannabinoid research2022

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom.

Jonathan Paul Liebling, Nicholas James Clarkson, Blair William Gibbs, Andrew Stephen Yates, Saoirse Elizabeth O'Sullivan

Open access · greenAbstract read
In one paragraph

Article in Cannabis and cannabinoid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Research and Clinical Practice Involving the Use ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Jonathan Paul LieblingCentre for Medicinal Cannabis, London, United Kingdom.
Nicholas James ClarksonPhytoVista Laboratories Ltd., Frome, United Kingdom.
Blair William GibbsCentre for Medicinal Cannabis, London, United Kingdom.
Andrew Stephen YatesCentre for Medicinal Cannabis, London, United Kingdom.
Saoirse Elizabeth O'SullivanCentre for Medicinal Cannabis, London, United Kingdom.
Gobierno de Canarias · ESIncyte (United States) · USUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabidiolCannabisControlled SubstancesDronabinolGas Chromatography-Mass SpectrometryCannabidiolControlled SubstancesDronabinolcannabidiolover the counterphytocannabinoidquality

Identifiers

PMID33998849
PMCPMC9070743
OpenAlexW3014244903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.